Treatment of the acute atopic outbreak. Anti-pruritic drugs: oclacitinib, lokivetmab and glucocorticoids. Control of secondary infections. Supportive topical treatment.
Long term-treatment of the atopic patient. Ciclosporin and allergen-specific immunotherapy.
Choosing the best option for each patient.
Other supportive treatments (food management, EFA supplements).
Language: English
Access: Live-Webinar with Q&A Session
Study Time: 1 hour
Date: 17 June 2020, 2 pm CST (Berlin, Paris)
17 June 2020, 7 pm UST+7 (Bangkok, Jakarta)
17 June 2020, 8 pm UST+8 (Beijing, Singapore)
17 June 2020, 9 pm UST+9 (Tokyo, Seoul)
17 June 2020, 10 pm UST+10 (Sydney)
You will have access to the recording of the webinar session for a total
duration of 3 days after the webinar happened in case you cannot attend
the webinar.
